Purchase Order 75N95023P00755
Award Date
9/11/23
Potential Completion Date
4/8/24
Potential Value
$23K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
University Of Kansas
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lawrence, KS 66045, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed-price purchase order valued at $19,500 to the University of Kansas Center for Research, Inc. to conduct abbreviated testing for the feasibility of developing a solid dosage form for Metarrestin. The solicitation requested the vendor modify existing potency and impurity assays, evaluate physicochemical properties, conduct feasibility studies for...
This $23,800.00 firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian federal agency, to the University of Kansas Center for Research Inc. on September 12, 2024. The contract is for preliminary solid dosage form development strategy of an ALDH1A1 inhibitor drug candidate for NCATS' Extramural Research and Training Branch (ETB). This contract does not have a set-aside designation. The University of Kansas Center for Research...
The University of Kansas Center for Research, Inc. was awarded a $24,000 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to conduct feasibility testing for a topically applied formulation for rodent testing of bacterial elongation factor inhibitors. The testing will support the agency's efforts to develop new antibiotics by evaluating delivery methods for candidate compounds. No subcontractors or set aside designations...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) to the University of Kansas Center for Research Inc., a non-profit subsidiary of the University of Kansas. The $20,000.00 contract supports structural studies of cofactor-independent phosphoglycerate mutases (iPGMs), which are enzymes involved in glycolysis. As the prime contractor, the University of Kansas Center for Research Inc. will perform this research. The award does not have a set-aside...
This is a $470,254.00 Firm Fixed Price Delivery Order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to The University of Iowa. The contract is part of the NCATS Drug Product Development Studies 2017-2022 Indefinite Delivery Vehicle (IDV) contract, which allows NCATS to issue task orders for specialized research services. This specific task order is for dosage form development, manufacturing, and stability studies of the drug compound...
<p>This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Pharmatek Laboratories, Inc., a for-profit manufacturer, for Formulation Development for RUC4. The contract, which does not have a set-aside designation, has a potential value of nineteen thousand dollars and a completion date of October 31, 2015. The place of performance is Potomac, Maryland.</p>
This is a federal contract award from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Pharmaron, Inc., a global contract research organization. The $281,751.22 purchase order contract is for a firm fixed price and does not have a set-aside designation. Under this contract, Pharmaron is conducting a variety of drug development activities to support the work of the NIH's National Center for Advancing Translational Sciences...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PGI Holding Corporation, a for-profit subchapter S corporation, to evaluate the efficacy of a nanoparticle formulation containing the drug aprepitant in a rodent model of neuropathic pain. The contract, valued at $216,900.00, has a period of performance from September 20, 2021 to March 31,...
This firm fixed price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Valued at $155,100, the contract calls for Frontage Laboratories Inc. to provide services in support of compound 21 testing and in vivo pharmacokinetics studies. Specifically, the prime contractor will scale up production of compound 21 to deliver 10...
The University of Kansas Center for Research, Inc. was awarded a $4,500 firm fixed price purchase order by the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism to provide support synthesizing 12 grams of carbamaathione. As the parent organization of the prime contractor, the University of Kansas will oversee contract performance. Dr. Fairman of the University of Kansas Center for Research will directly perform the technical efforts of synthesizing the...